Biotech Values

[iwfal]

Does that apply to generic launches?

I have never watched a generic launch before. Hence my interest - and hence my use of the qualifier, 'limited' experience.

But nonetheless I can't think of any particular reasons that it would be substantially easier to segregate channel filling from end user demand for a generic launch.